The ERC’s mission is to encourage the highest quality research in Europe through competitive funding and to support investigator-initiated frontier research across all fields of research, on the basis of scientific excellence. Being ‘investigator-driven’, or ‘bottom-up’, in nature, the ERC approach allows researchers to identify new opportunities and directions in any field of research, rather than being led by priorities set by politicians.
margot.beereboom@fwo.be
+32 2 550 15 76
The ERC’s mission is to encourage the highest quality research in Europe through competitive funding and to support investigator-initiated frontier research across all fields of research, on the basis of scientific excellence. Being ‘investigator-driven’, or ‘bottom-up’, in nature, the ERC approach allows researchers to identify new opportunities and directions in any field of research, rather than being led by priorities set by politicians.
Five ERC frontier research grants will be available under the ERC Work Programme 2020.
The ERC Scientific Council has analysed the pilot phase of the ERC Synergy Grant (calls were made under Work Programmes 2012 and 2013) and decided to reintroduce the call for Synergy grants under the Work Programme 2018.
ERC Principal Investigators will also continue to be able to apply for the Proof of Concept Grant, first introduced under the revised Work Programme 2011.
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.